What I have: batch certificate · FGP.
This is presented as though it settles something, and I am not convinced it does.
I have two documents that appear to disagree, which is what prompted this.
Which parts of this are informative and which are decoration?
The certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Stated carefully, test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemReading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
On the detail: a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
If the certificate does not trace to your vial, it is not evidence about your vial.
What makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 27 Aug 2025 by tabular_nums — fixed an arithmetic slip in the third paragraph
Concretely, the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.